Cargando…
Integrated multi-omics data analysis identifying novel drug sensitivity-associated molecular targets of hepatocellular carcinoma cells
Hepatocellular carcinoma (HCC) is the most common type of liver cancer and the third-leading cause of malignancy-associated mortality worldwide. HCC cells are highly resistant to chemotherapeutic agents. Therefore, there are currently only two US Food and Drug Administration-approved drugs available...
Autor principal: | Yildiz, Gokhan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6006500/ https://www.ncbi.nlm.nih.gov/pubmed/29930714 http://dx.doi.org/10.3892/ol.2018.8634 |
Ejemplares similares
-
Multi-omics data integration reveals novel drug targets in hepatocellular carcinoma
por: Dimitrakopoulos, Christos, et al.
Publicado: (2021) -
Multi-omics data integration for hepatocellular carcinoma subtyping with multi-kernel learning
por: Wang, Jiaying, et al.
Publicado: (2022) -
Identifying tumor immunity-associated molecular features in liver hepatocellular carcinoma by multi-omics analysis
por: Shen, Qianyun, et al.
Publicado: (2022) -
Identifying subpathway signatures for individualized anticancer drug response by integrating multi-omics data
por: Xu, Yanjun, et al.
Publicado: (2019) -
Integrated Multi-Omics Data Analysis Reveals Associations Between Glycosylation and Stemness in Hepatocellular Carcinoma
por: Liu, Peiyan, et al.
Publicado: (2022)